PASD1 is a potential multiple myeloma-associated antigen. :: UTM Library Massive Scholar Tracking

ग्रंथसूची विवरण
मुख्य लेखकों:	Sahota, S, Goonewardena, C, Cooper, C, Liggins, A, Ait-Tahar, K, Zojer, N, Stevenson, F, Banham, A, Pulford, K
स्वरूप:	Journal article
भाषा:	English
प्रकाशित:	2006

DNA vaccines to target the cancer testis antigen PASD1 in human multiple myeloma.
द्वारा: Joseph-Pietras, D, और अन्य
प्रकाशित: (2010)

Cytotoxic T-Cell Response to the Cancer Testis Antigen PASD1 In Multiple Myeloma: PASD1 Peptides for a Generic Vaccine to Treat PASD1-Positive Haematological Malignancies.
द्वारा: Campbell, A, और अन्य
प्रकाशित: (2010)

PASD1, a DLBCL-associated cancer testis antigen and candidate for lymphoma immunotherapy.
द्वारा: Cooper, C, और अन्य
प्रकाशित: (2006)

Cytolytic T-cell response to the PASD1 cancer testis antigen in patients with diffuse large B-cell lymphoma.
द्वारा: Ait-Tahar, K, और अन्य
प्रकाशित: (2009)

Cytotoxic T-cell response to the PASD1 protein in patients with diffuse large B-cell lymphoma
द्वारा: Ait-Tahar, K, और अन्य
प्रकाशित: (2009)

CD4-positive T-helper cell responses to the PASD1 protein in patients with diffuse large B-cell lymphoma.
द्वारा: Ait-Tahar, K, और अन्य
प्रकाशित: (2011)

CD4-positive T-helper cell responses to the PASD1 protein in patients with diffuse large B-cell lymphoma
द्वारा: Kamel Ait-Tahar, और अन्य
प्रकाशित: (2011-01-01)

Identification and characterization of peripheral T-cell lymphoma-associated SEREX antigens.
द्वारा: Cooper, C, और अन्य
प्रकाशित: (2011)

Serologic detection of diffuse large B-cell lymphoma-associated antigens.
द्वारा: Liggins, A, और अन्य
प्रकाशित: (2004)

Erratum: Serologic detection of diffuse large B-cell lymphoma-associated antigens (International Journal of Cancer (2004) 110 (563-569))
द्वारा: Liggins, A, और अन्य
प्रकाशित: (2004)

A novel diffuse large B-cell lymphoma-associated cancer testis antigen encoding a PAS domain protein.
द्वारा: Liggins, A, और अन्य
प्रकाशित: (2004)

Identification of lymphoma-associated antigens using SEREX.
द्वारा: Liggins, A, और अन्य
प्रकाशित: (2005)

Immunochemical studies of antigenic lymphoma-associated proteins.
द्वारा: Pulford, K, और अन्य
प्रकाशित: (2002)

A panel of cancer-testis genes exhibiting broad-spectrum expression in haematological malignancies
द्वारा: Liggins, A, और अन्य
प्रकाशित: (2010)

A panel of cancer-testis genes exhibiting broad-spectrum expression in haematological malignancies.
द्वारा: Liggins, A, और अन्य
प्रकाशित: (2010)

Identification and characterization of peripheral T-cell lymphoma-associated SEREX antigens.
द्वारा: Christopher D O Cooper, और अन्य
प्रकाशित: (2011-01-01)

MORC4, a novel member of the MORC family, is highly expressed in a subset of diffuse large B-cell lymphomas.
द्वारा: Liggins, A, और अन्य
प्रकाशित: (2007)

Sp17 protein expression and major histocompatibility class I and II epitope presentation in diffuse large B cell lymphoma patients
द्वारा: Ait-Tahar, K, और अन्य
प्रकाशित: (2017)

Cancer testis antigens in newly diagnosed and relapse multiple myeloma: prognostic markers and potential targets for immunotherapy
द्वारा: Mark van Duin, और अन्य
प्रकाशित: (2011-11-01)

P08 TEMPORAL TRENDS IN PROGNOSIS OF PATIENTS WITH SMOLDERING MULTIPLE MYELOMA (SMM) WHO MEET CRITERIA FOR BIOMARKER-DEFINED EARLY MULTIPLE MYELOMA (SLIM CRAB POSITIVE MM)
द्वारा: H. Ludwig, और अन्य
प्रकाशित: (2023-05-01)

Identification of Huntingtin Interacting Protein 1 Related (HIP1R) as a Novel Lymphoma Autoantigen Using Antigen Array Profiling
द्वारा: Wong, K, और अन्य
प्रकाशित: (2008)

Identification of Huntingtin interacting protein 1 related (HIP1R) as a novel lymphoma autoantigen using antigen array profiling
द्वारा: Wong, K, और अन्य
प्रकाशित: (2009)

Humoral detection of leukaemia-associated antigens in presentation acute myeloid leukaemia.
द्वारा: Guinn, B, और अन्य
प्रकाशित: (2005)

B and CTL responses to the ALK protein in patients with ALK-positive ALCL.
द्वारा: Ait-Tahar, K, और अन्य
प्रकाशित: (2006)

EXPRESSION OF CANCER-TESTIS GENES PRAME, NY-ESO1, GAGE1, MAGE A3, MAGE A6, MAGE A12, SSX1, SLLP1, PASD1 IN PATIENTS WITH MULTIPLE MYELOMA, THEIR INFLUENCE ON OVERALL SURVIVAL AND RELAPSE RATE
द्वारा: A. A. Solodovnik, और अन्य
प्रकाशित: (2018-07-01)

Therapeutic targeting of FOXP3-positive regulatory T cells using a FOXP3 peptide vaccine WO2008081581.
द्वारा: Banham, A, और अन्य
प्रकाशित: (2009)

Bortezomib for the treatment of multiple myeloma patients
द्वारा: C Green, और अन्य
प्रकाशित: (2009-06-01)

Synergistic interaction between HDAC and MCL-1 inhibitors through downregulation of BCL-XL in multiple myeloma
द्वारा: Anja Schneller, और अन्य
प्रकाशित: (2021-04-01)

CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA
द्वारा: Ugo Testa, और अन्य
प्रकाशित: (2024-10-01)

Chimeric antigen receptor T-cell therapy for multiple myeloma
द्वारा: Zehua Wang, और अन्य
प्रकाशित: (2022-12-01)

Chimeric antigen receptor T cell therapies for multiple myeloma
द्वारा: Chao Wu, और अन्य
प्रकाशित: (2019-11-01)

Chimeric antigen receptor T cell therapy for multiple myeloma
द्वारा: Kana Hasegawa, और अन्य
प्रकाशित: (2019-06-01)

Extramedullary Myeloma to the Liver Following Bispecific Antigen T-Cell Treatment for Refractory Multiple Myeloma
द्वारा: Joelle St-Pierre, और अन्य
प्रकाशित: (2022-01-01)

SLiM CRAB criteria revisited: temporal trends in prognosis of patients with smoldering multiple myeloma who meet the definition of ‘biomarker-defined early multiple myeloma’—a systematic review with meta-analysisResearch in context
द्वारा: Heinz Ludwig, और अन्य
प्रकाशित: (2023-04-01)

Regulation of antigen-specific T cell infiltration and spatial architecture in multiple myeloma and premalignancy
द्वारा: M. Hope Robinson, और अन्य
प्रकाशित: (2023-08-01)

eNSMBL-PASD: Spearheading early autism spectrum disorder detection through advanced genomic computational frameworks utilizing ensemble learning models
द्वारा: Ayesha Karim, और अन्य
प्रकाशित: (2025-01-01)

Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma.
द्वारा: Lawrie, C, और अन्य
प्रकाशित: (2008)

Soluble B-cell maturation antigen in lacrimal fluid as a potential biomarker and mediator of keratopathy in multiple myeloma
द्वारा: Umair Munawar, और अन्य
प्रकाशित: (2024-04-01)

Chimeric antigen receptor T-cell therapy for multiple myeloma: a consensus statement from The European Myeloma Network
द्वारा: Philippe Moreau, और अन्य
प्रकाशित: (2019-12-01)

Onset of multiple myeloma with rheumatic polymyalgia
द्वारा: E. R. Israelyan, और अन्य
प्रकाशित: (2019-12-01)

PASD1 is a potential multiple myeloma-associated antigen.

समान संसाधन

समान संसाधन